US Patent Issued to Ascensia Diabetes Care Holdings on May 20 for "Devices, systems, and methods for measuring analytes in interstitial fluid" (New York Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,261, issued on May 20, was assigned to Ascensia Diabetes Care Holdings AG (Basel, Switzerland).

"Devices, systems, and methods for measuring analytes in interstitial fluid" was invented by Igor Y. Gofman (Croton-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An analyte monitor includes a controller including a processor coupled to a memory. The memory has instructions stored therein that, when executed by the processor, cause the controller to: provide a working electrode voltage to a working electrode of an analyte sensor; selectively provide a first counter electrode voltage and a second counter electrode voltage to a counter elect...